Loading...

Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD

Patients with CKD often progress to ESRD and develop cardiovascular disease (CVD), yet available therapies only modestly improve clinical outcomes. Observational studies report independent associations between elevated serum phosphate and fibroblast growth factor 23 (FGF23) levels and risks of ESRD,...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Am Soc Nephrol
Main Authors: Isakova, Tamara, Ix, Joachim H., Sprague, Stuart M., Raphael, Kalani L., Fried, Linda, Gassman, Jennifer J., Raj, Dominic, Cheung, Alfred K., Kusek, John W., Flessner, Michael F., Wolf, Myles, Block, Geoffrey A.
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Nephrology 2015
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4587706/
https://ncbi.nlm.nih.gov/pubmed/25967123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2015020117
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!